Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 06 05 2023
accepted: 01 07 2023
revised: 29 06 2023
medline: 9 11 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: ppublish

Résumé

The diagnosis of patients with mutations in the VCP gene can be complicated due to their broad phenotypic spectrum including myopathy, motor neuron disease and peripheral neuropathy. Muscle MRI guides the diagnosis in neuromuscular diseases (NMDs); however, comprehensive muscle MRI features for VCP patients have not been reported so far. We collected muscle MRIs of 80 of the 255 patients who participated in the "VCP International Study" and reviewed the T1-weighted (T1w) and short tau inversion recovery (STIR) sequences. We identified a series of potential diagnostic MRI based characteristics useful for the diagnosis of VCP disease and validated them in 1089 MRIs from patients with other genetically confirmed NMDs. Fat replacement of at least one muscle was identified in all symptomatic patients. The most common finding was the existence of patchy areas of fat replacement. Although there was a wide variability of muscles affected, we observed a common pattern characterized by the involvement of periscapular, paraspinal, gluteal and quadriceps muscles. STIR signal was enhanced in 67% of the patients, either in the muscle itself or in the surrounding fascia. We identified 10 diagnostic characteristics based on the pattern identified that allowed us to distinguish VCP disease from other neuromuscular diseases with high accuracy. Patients with mutations in the VCP gene had common features on muscle MRI that are helpful for diagnosis purposes, including the presence of patchy fat replacement and a prominent involvement of the periscapular, paraspinal, abdominal and thigh muscles.

Sections du résumé

BACKGROUND BACKGROUND
The diagnosis of patients with mutations in the VCP gene can be complicated due to their broad phenotypic spectrum including myopathy, motor neuron disease and peripheral neuropathy. Muscle MRI guides the diagnosis in neuromuscular diseases (NMDs); however, comprehensive muscle MRI features for VCP patients have not been reported so far.
METHODS METHODS
We collected muscle MRIs of 80 of the 255 patients who participated in the "VCP International Study" and reviewed the T1-weighted (T1w) and short tau inversion recovery (STIR) sequences. We identified a series of potential diagnostic MRI based characteristics useful for the diagnosis of VCP disease and validated them in 1089 MRIs from patients with other genetically confirmed NMDs.
RESULTS RESULTS
Fat replacement of at least one muscle was identified in all symptomatic patients. The most common finding was the existence of patchy areas of fat replacement. Although there was a wide variability of muscles affected, we observed a common pattern characterized by the involvement of periscapular, paraspinal, gluteal and quadriceps muscles. STIR signal was enhanced in 67% of the patients, either in the muscle itself or in the surrounding fascia. We identified 10 diagnostic characteristics based on the pattern identified that allowed us to distinguish VCP disease from other neuromuscular diseases with high accuracy.
CONCLUSIONS CONCLUSIONS
Patients with mutations in the VCP gene had common features on muscle MRI that are helpful for diagnosis purposes, including the presence of patchy fat replacement and a prominent involvement of the periscapular, paraspinal, abdominal and thigh muscles.

Identifiants

pubmed: 37603075
doi: 10.1007/s00415-023-11862-4
pii: 10.1007/s00415-023-11862-4
pmc: PMC10632218
doi:

Substances chimiques

Valosin Containing Protein EC 3.6.4.6
VCP protein, human EC 3.6.4.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5849-5865

Subventions

Organisme : Academy of Medical Sciences
ID : Professorship Scheme APR4/1007
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W019086/1
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Skeletal Radiol. 2007 Jul;36(7):609-26
pubmed: 17410356
Int J Mol Sci. 2020 May 28;21(11):
pubmed: 32481679
J Neurol. 2020 Jan;267(1):45-56
pubmed: 31555977
Neuromuscul Disord. 2009 May;19(5):308-15
pubmed: 19380227
Neuromuscul Disord. 2019 Nov;29(11):827-841
pubmed: 31727541
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):72-77
pubmed: 28889091
JAMA Neurol. 2016 Sep 1;73(9):1105-14
pubmed: 27400454
Neurology. 2012 Nov 27;79(22):2201-8
pubmed: 23152587
Acta Myol. 2015 Dec;34(2-3):95-108
pubmed: 27199536
Ann Neurol. 2016 May;79(5):854-864
pubmed: 26994363
Front Neurol. 2019 Feb 11;10:78
pubmed: 30804884
Genet Med. 2000 Jul-Aug;2(4):232-41
pubmed: 11252708
Orphanet J Rare Dis. 2022 Jan 29;17(1):23
pubmed: 35093159
Neuromuscul Disord. 2011 Aug;21(8):551-5
pubmed: 21684747
AJR Am J Roentgenol. 2011 Jun;196(6 Suppl):S64-75
pubmed: 21606236
Mol Genet Genomic Med. 2023 Jul;11(7):e2176
pubmed: 37002192
Neuromuscul Disord. 2020 Mar;30(3):232-235
pubmed: 32165109
PLoS One. 2013 Aug 14;8(8):e70993
pubmed: 23967145
Acta Myol. 2017 Dec 01;36(4):203-206
pubmed: 29770363
Muscle Nerve. 2021 Apr;63(4):442-454
pubmed: 33145792
Mol Brain. 2016 Mar 22;9:31
pubmed: 27000202
Neuron. 2010 Dec 9;68(5):857-64
pubmed: 21145000
Nat Genet. 2004 Apr;36(4):377-81
pubmed: 15034582
Eur J Radiol. 2022 Oct;155:110475
pubmed: 35998441
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):680-1
pubmed: 26105173
Neuromuscul Disord. 2021 Aug;31(8):701-705
pubmed: 34244020
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1071-1081
pubmed: 29735511
Curr Opin Neurol. 2020 Oct;33(5):611-620
pubmed: 32796278
PLoS One. 2014 Jun 16;9(6):e100292
pubmed: 24932477
Neuromuscul Disord. 2016 Aug;26(8):535-47
pubmed: 27312024
J Neurol Neurosurg Psychiatry. 2022 Jul 27;:
pubmed: 35896379
Neuromuscul Disord. 2020 Nov;30(11):938-947
pubmed: 33004285
Neuromuscul Disord. 2022 Feb;32(2):142-149
pubmed: 35033413
Ann Neurol. 2020 Oct;88(4):669-681
pubmed: 32495452
Radiographics. 2002 Sep-Oct;22(5):1191-216
pubmed: 12235348
J Med Genet. 2012 Jan;49(1):41-6
pubmed: 21984748
BMC Neurol. 2022 Nov 3;22(1):406
pubmed: 36329418
Neurology. 2020 Mar 10;94(10):e1094-e1102
pubmed: 32029545
Muscle Nerve. 2015 Dec;52(6):956-62
pubmed: 25808807
Brain. 2014 Nov;137(Pt 11):2897-902
pubmed: 25125609
Proteomics Clin Appl. 2009 Apr;3(4):486-97
pubmed: 21136973
Inflammation. 2017 Feb;40(1):21-41
pubmed: 27730320
Brain. 2012 Dec;135(Pt 12):e223; author reply e224
pubmed: 22991237
Eur J Neurol. 2013 Feb;20(2):251-8
pubmed: 22900631
Mol Genet Metab. 2001 Dec;74(4):458-75
pubmed: 11749051
Radiographics. 2003 Mar-Apr;23(2):341-58
pubmed: 12640151
Eur J Radiol. 2021 Aug;141:109812
pubmed: 34118766
J Neurol. 2017 Jul;264(7):1334-1342
pubmed: 28503705

Auteurs

Diana Esteller (D)

Neurology Department, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain.

Marianela Schiava (M)

John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.

Rocío-Nur Villar-Quiles (RN)

APHP, Centre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.

Boris Dibowski (B)

Department of Radiology, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Start Imaging, Raymond Poincaré Teaching Hospital, Garches, France.

Nadia Venturelli (N)

Department of Radiology, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Start Imaging, Raymond Poincaré Teaching Hospital, Garches, France.

Pascal Laforet (P)

Département de Neurologie Hôpital Raymond-Poincaré Garches France Inserm U1179, Garches, France.

Jorge Alonso-Pérez (J)

Servicio de Neurología. Hospital Virgen de la Candelaria, Tenerife, Spain.
Neuromuscular Diseases Unit, Neurology Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Montse Olive (M)

Neuromuscular Diseases Unit, Neurology Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Cristina Domínguez-González (C)

Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Unidad de Enfermedades Neuromusculares, Servicio de Neurología, Instituto de Investigación imas12, Hospital 12 de Octubre, Madrid, Spain.

Carmen Paradas (C)

Unidad de Enfermedades Neuromusculares, Servicio de Neurología, Hospital Virgen del Rocio, Seville, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.

Beatriz Vélez (B)

Unidad de Enfermedades Neuromusculares, Servicio de Neurología, Hospital Virgen del Rocio, Seville, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.

Anna Kostera-Pruszczyk (A)

Department of Neurology, Medical University of Warsaw, ERN EURO NMD, Warsaw, Poland.
Neuromuscular Reference Centre, ERN-EURO-NMD, Warsaw, Poland.

Biruta Kierdaszuk (B)

Department of Neurology, Medical University of Warsaw, ERN EURO NMD, Warsaw, Poland.
Neuromuscular Reference Centre, ERN-EURO-NMD, Warsaw, Poland.

Carmelo Rodolico (C)

UOC di Neurologia e Malattie Neuromuscolari, AOU Policlinico "G. Martino", Rome, Italy.

Kristl Claeys (K)

Neurologie, Neuromusculair Referentiecentrum, Universitaire Ziekenhuizen, Leuven, Belgium.

Endre Pál (E)

Neurology Department, University of Pécs, Pécs, Hungary.

Edoardo Malfatti (E)

Université Paris Est, U955 INSERM, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor Hospital, EURO-NMD, 94010, Creteil, France.

Sarah Souvannanorath (S)

Université Paris Est, U955 INSERM, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor Hospital, EURO-NMD, 94010, Creteil, France.

Alicia Alonso-Jiménez (A)

Neurology Department, Universitary Hospital Antwerpen, Edegem, Belgium.

Willem de Ridder (W)

Neurology Department, Universitary Hospital Antwerpen, Edegem, Belgium.

Eline De Smet (E)

Neurology Department, Universitary Hospital Antwerpen, Edegem, Belgium.

George Papadimas (G)

Department of Neurology, Eginition Hospital, Medical School, NKUA, ERN, EURO NMD, Athens, Greece.

Constantinos Papadopoulos (C)

Department of Neurology, Eginition Hospital, Medical School, NKUA, ERN, EURO NMD, Athens, Greece.

Sofia Xirou (S)

Department of Neurology, Eginition Hospital, Medical School, NKUA, ERN, EURO NMD, Athens, Greece.

Sushan Luo (S)

Neurology Department, Huashan Hospital, Fudan University, Shangai, China.

Nuria Muelas (N)

Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Neuromuscular Diseases Unit, Neurology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Department of Medicine, Universitat de València, Valencia, Spain.

Juan J Vilchez (JJ)

Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Neuromuscular Diseases Unit, Neurology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Department of Medicine, Universitat de València, Valencia, Spain.

Alba Ramos-Fransi (A)

Unitat de Malalties Neuromusculars, Servei de Neurologia, Hospital Germans Tries I Pujol, Badalona, Spain.

Mauro Monforte (M)

UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giorgio Tasca (G)

John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.

Bjarne Udd (B)

Tampere Neuromuscular Center, Tampere University Hospital, Tampere, Finland.
Folkhalsan Genetic Institute, Helsinki University, Helsinki, Finland.

Johanna Palmio (J)

Tampere Neuromuscular Center, Tampere University Hospital, Tampere, Finland.
Folkhalsan Genetic Institute, Helsinki University, Helsinki, Finland.

Srtuhi Sri (S)

Sree Chitra Tirunal Insitute for Medical Sciences and Technology, Thiruvananthapuram, India.

Sabine Krause (S)

Department of Neurology, Friedrich-Baur-Institute, LMU Clinics, Munich, Germany.

Benedikt Schöser (B)

Department of Neurology, Friedrich-Baur-Institute, LMU Clinics, Munich, Germany.

Roberto Fernández-Torrón (R)

Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Neurology Department, Biodonostia Health Research Institute, Donostia, Spain.

Adolfo López de Munain (A)

Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Neurology Department, Biodonostia Health Research Institute, Donostia, Spain.

Elena Pegoraro (E)

Department of Neurosciences, University of Padova, Padua, Italy.

Maria Elena Farrugia (ME)

Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, Scotland, UK.

Mathias Vorgerd (M)

Heimer Institut for Muscle Research, Klinikum Bergmannsheil Ruhr, University Bochum, Bochum, Germany.

Georgious Manousakis (G)

University of Minnesota, Minneapolis, USA.

Jean Baptiste Chanson (JB)

Centre de Référence des Maladies Neuromusculaires Nord/Est/Ile-de-France and ERN-EURO-NMD, Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Aleksandra Nadaj-Pakleza (A)

Centre de Référence des Maladies Neuromusculaires Nord/Est/Ile-de-France and ERN-EURO-NMD, Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Hakan Cetin (H)

Neurology Department, Medical University of Vienna, Vienna, Austria.

Umesh Badrising (U)

Leiden University Medical Center, Leiden, The Netherlands.

Jodi Warman-Chardon (J)

Department of Medicine (Neurology), The Ottawa Hospital, Ottawa, Canada.

Jorge Bevilacqua (J)

Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.

Nicholas Earle (N)

Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.

Mario Campero (M)

Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.

Jorge Díaz (J)

Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.

Chiseko Ikenaga (C)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.

Thomas E Lloyd (TE)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology, Tokyo, Japan.

Yukako Nishimori (Y)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology, Tokyo, Japan.

Yoshihiko Saito (Y)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology, Tokyo, Japan.

Yasushi Oya (Y)

Department of Neurology, National Center Hospital, NCNP, Tokyo, Japan.

Yoshiaki Takahashi (Y)

Department of Neurology, Kagawa Prefectural Central Hospital, Kagawa, Japan.

Atsuko Nishikawa (A)

Department of Neurology, Kinki Central Hospital, Hyogo, Japan.

Ryo Sasaki (R)

Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Chiara Marini-Bettolo (C)

John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.

Michela Guglieri (M)

John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.

Volker Straub (V)

John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.

Tanya Stojkovic (T)

APHP, Centre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.

Robert Y Carlier (RY)

Department of Radiology, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Start Imaging, Raymond Poincaré Teaching Hospital, Garches, France.

Jordi Díaz-Manera (J)

John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom. Jordi.diaz-manera@newcastle.ac.uk.
Neuromuscular Diseases Unit, Neurology Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Jordi.diaz-manera@newcastle.ac.uk.
Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. Jordi.diaz-manera@newcastle.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH